Sign In
Buy NVO
$47.42
+1.52 (+3.31%)
At Close: Jun 23, 2026
SNY vs. NVO: Which Stock Should Value Investors Buy Now?
12:48pm, Friday, 17'th Feb 2023
SNY vs. NVO: Which Stock Is the Better Value Option?
Competition Coming For AbbVie's Blockbuster Humira
01:08am, Thursday, 16'th Feb 2023
It's among the prohibitively expensive biologic pharmaceuticals being replaced by cheaper “biosimilar” copycats. Relief is on the way for patients who need Humira, a product made by AbbVie.
New Strong Buy Stocks for February 14th
09:02am, Tuesday, 14'th Feb 2023
INSP, ALK, SSKN, NVO and TBPH have been added to the Zacks Rank #1 (Strong Buy) List on February 14, 2023.
2 Market-Beating Growth Stocks That Are Just Getting Started
09:53am, Friday, 10'th Feb 2023
Winners keep winning.
How To Allocate $5,000 Among 5 Dividend Income And Dividend Growth Stocks And ETFs
09:48am, Thursday, 09'th Feb 2023
In this article, I will show you a portfolio that consists of 5 picks that provide you with Dividend Income and Dividend Growth. When allocating $5,000 between 5 stocks, I would not recommend allocati
Novo Nordisk CEO on safety concerns associated with off-label use of diabetes drugs
04:22pm, Monday, 06'th Feb 2023
CNBC's Meg Tirrell joins 'Closing Bell' to report on rapid prescription growth for diabetes medicine, celebrities using Ozempic and Wegovy for weight loss and the safety related to broad use of medici
Novo Nordisk (NVO) Q4 Earnings Beat Estimates, Revenues Miss
03:03pm, Wednesday, 01'st Feb 2023
Novo Nordisk (NVO) reports mixed results for Q4 as earnings beat estimates but sales miss on the same. Sales are aided by growth in Diabetes and Obesity Care on higher GLP-1 revenues.
SNY or NVO: Which Is the Better Value Stock Right Now?
12:47pm, Wednesday, 01'st Feb 2023
SNY vs. NVO: Which Stock Is the Better Value Option?
Novo Nordisk A/S (NVO) Q4 2022 Earnings Call Transcript
11:34am, Wednesday, 01'st Feb 2023
Novo Nordisk A/S (NVO) Q4 2022 Earnings Conference Call February 1, 2023 7:00 AM ET Company Participants Lars Fruergaard Jørgensen - President and Chief Executive Officer Camilla Sylvest - Executive
Pharma Giants GSK, Novo Nordisk Beat Expectations; But Novartis Dives On A Mixed Report
09:16am, Wednesday, 01'st Feb 2023
GSK stock and NVO stock rose Wednesday on fourth-quarter beats, but Novartis stock fell on lighter-than-expected sales despite strong profit. The post Pharma Giants GSK, Novo Nordisk Beat Expectations
Novo Nordisk Sees Obesity Drug Fueling Record Profit
05:18am, Wednesday, 01'st Feb 2023
Novo Nordisk President and Chief Executive Officer Lars Fruergaard Jorgensen discusses soaring demand for the company's obesity drug Wegovy with Francine Lacqua on "Bloomberg Surveillance Early Editio
Novo Nordisk lifts dividend, launches $4.09 billion share buyback after earnings beat forecasts
02:25am, Wednesday, 01'st Feb 2023
Danish pharmaceutical company Novo Nordisk AS DK:NOVO.B NVO on Wednesday raised its dividend and launched a new 28 billion Danish kroner ($4.09 billion) share buyback after fourth-quarter earnings bea
A Dividend Aristocrat That Could Crash And One That Could Potentially Triple
07:30am, Tuesday, 31'st Jan 2023
Dividend aristocrats are some of the world's safest and most dependable companies. Exactly the kinds of companies you want in a recession. But not all dividend aristocrats are safe buys. Some are almo
3 Global Stocks to Buy to Get Around America's Slowdown
03:43pm, Monday, 30'th Jan 2023
If you've been avoiding stocks during the past few months in order to prevent yourself from making any more mistakes after 2022's bloodbath and you're looking to dip your toe back into equities, findi
U.S. Appeals Court Sides With Drugmakers on Discount Program
02:38pm, Monday, 30'th Jan 2023
The court ruled that drugmakers can limit their shipments of federally-discounted drugs to pharmacies, in a blow to hospitals and clinics.
